Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

JPMorgan stock PT raised at Barclays following earnings beat

EditorRachael Rajan
Published 10/14/2024, 07:44 PM
© Reuters.
JPM
-

On Monday, Barclays updated its stance on JPMorgan Chase & Co. (NYSE: NYSE:JPM), increasing its price target to $257 from the previous figure of $217, while maintaining an Overweight rating on the stock.

The adjustment comes after JPMorgan reported earnings that surpassed expectations, with notable performance in net interest income (NII), which was in line with the net interest margin (NIM), as well as fees from trading and investment banking that exceeded guidance. The bank also saw better-than-expected control over expenses and an accelerated pace in share repurchases.

Despite these positive outcomes, a higher-than-anticipated provision for credit losses, which was offset by improved net charge-offs (NCOs), limited the potential for further earnings enhancements.

Looking ahead, JPMorgan has updated its financial forecasts, indicating an improvement in its 2024 NII and expense outlook. However, for 2025, the bank anticipates a decrease in NII and an increase in expenses.

JPMorgan Chase reported a robust third-quarter performance, with a net income of $12.9 billion, earnings per share of $4.37, and total revenue of $43.3 billion, marking a 6% year-on-year increase. Evercore ISI responded to these strong results by raising JPMorgan's price target to $230 from $217, while maintaining an Outperform rating. Citi, however, kept its Neutral rating with a price target of $215.

Analysts from Evercore ISI highlighted JPMorgan's potential growth in the second half of 2025, citing strong performances in investment banking, asset and wealth management, and card services. Citi's analysis implies a 55% cumulative downward rate beta by early 2026, suggesting that actual figures may surpass current consensus estimates by 2026.

InvestingPro Insights

JPMorgan Chase & Co.'s strong performance, as highlighted in the Barclays update, is further supported by real-time data from InvestingPro. The bank's market capitalization stands at an impressive $625.81 billion, reflecting its position as a prominent player in the banking industry. This aligns with the InvestingPro Tip that JPMorgan is a "Prominent player in the Banks industry."

The company's P/E ratio of 12.37 suggests that it's trading at a relatively reasonable valuation, especially considering its strong financial performance. JPMorgan's revenue for the last twelve months as of Q3 2024 reached $159.44 billion, with a notable revenue growth of 11.96% over the same period. This growth trend supports the bank's positive earnings report mentioned in the article.

An InvestingPro Tip indicates that JPMorgan "Has raised its dividend for 14 consecutive years," which is a testament to its financial stability and commitment to shareholder returns. This is particularly relevant given the bank's accelerated pace in share repurchases noted in the article.

For investors seeking more comprehensive insights, InvestingPro offers 11 additional tips for JPMorgan Chase & Co., providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.